Test Bank Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th E By Woo | Complete Study Guide.

Test Bank Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th E By Woo
bg bg bg bg bg bg bg bg bg bg bg




Pharmacotherapeutics for Advanced Practice bg bg bg




NursePrescribers 5th Edition Woo Robinson Test
bg b
g bg bg bg bg bg




Bank
bg




Chapter 1. The Role of the Nurse Practitioner as Prescriber
bg bg bg bg bg bg bg bg bg




Chapter 2. Review of the Basic Principles of
bg bg bg bg bg bg bg bg




PharmacologyChapter 3. Rational Drug Selection
bg bg bg bg bg bg




Chapter 4. Legal and Professional Issues in
bg bg bg bg bg bg




PrescribingChapter 5. Adverse Drug Reactions
bg bg bg bg bg bg




Chapter 6. Pharmacogenetics
bg bg




Chapter 7. Nutrition and Neutraceuticals
bg bg bg bg




Chapter 8. Herbal Therapies and
bg bg bg bg bg




CannabisChapter 9. Informatics
bg bg bg bg




Chapter 10. Pharmacoeconomics
bg bg




Chapter 11. Drugs Affecting the Autonomic Nervous
bg bg bg bg bg bg




SystemChapter 12. Drugs Affecting the Central Nervous
bg bg bg bg bg bg bg bg




System
bg




Chapter 13. Drugs Affecting the Cardiovascular and Renal
bg bg bg bg bg bg bg




SystemsChapter 14. Drugs Affecting the Respiratory System
bg bg bg bg bg bg bg bg




Chapter 15. Drugs Affecting the Hematological System
bg bg bg bg bg bg




Chapter 16. Drugs Affecting the Immune System
bg bg bg bg bg bg bg




Chapter 17. Drugs Affecting the Gastrointestinal System
bg bg bg bg bg bg bg




Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones
bg bg bg bg bg bg bg bg




andAntidiabetic Drugs
bg g
b bg




Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid,
bg bg bg bg bg bg bg bg




andAdrenal Drugs
bg g
b bg




Chapter 20. Drugs Affecting the Reproductive System
bg bg bg bg bg bg




Chapter 21. Drugs Affecting the Bones and Joints
bg bg bg bg bg bg bg bg




Chapter 22. Drugs Affecting the Integumentary
bg bg bg bg bg bg




SystemChapter 23. Drugs Used to Treat Bacterial
bg bg bg bg bg bg bg bg




Infections
bg




Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal
bg bg bg bg bg bg bg bg bg




InfectionsChapter 25. Drugs Used to Treat Inflammatory Processes
bg bg bg bg bg bg bg bg bg




Chapter 26. Drugs Used to Treat Eye and Ear
bg bg bg bg bg bg bg bg




DisordersChapter 27. Alcohol and Drug Addiction
bg bg bg bg bg bg bg




Chapter 28. Anemia bg bg




Chapter 29. Angina bg bg




Chapter 30. Anxiety and Depression
bg bg bg bg




Chapter 31. Attention Deficit Hyperactivity Disorder
bg bg bg bg bg




Chapter 32. Asthma and Chronic Obstructive Pulmonary
bg bg bg bg bg bg




DiseaseChapter 33. Contraception
bg bg bg bg




Chapter 34. Dermatological
bg bg




ConditionsChapter 35. Diabetes
bg bg bg bg




Management
bg




Chapter 36. Gastroesophageal Reflux and Peptic Ulcer
bg bg bg bg bg bg




DiseaseChapter 37. Headaches
bg bg bg bg




Chapter 38. Heart Failure bg bg bg




Chapter 39. Human Immunodeficiency Virus Disease and Acquired
bg bg bg bg bg bg bg




ImmunodeficiencySyndrome
bg bg




Chapter 40. Hormone Replacement
bg bg bg




TherapyChapter 41. Hyperlipidemia
bg bg bg bg




Chapter 42. Hypertension
bg bg




Chapter 43. Hyperthyroidism and Hypothyroidism
bg bg bg bg




Chapter 44. Pain Management: Acute and Chronic
bg bg bg bg bg bg bg




PainChapter 45. Pneumonia
bg g
b bg bg




Chapter 46. Smoking Cessation
bg bg bg




Chapter 47. Sexually Transmitted Diseases and
bg bg bg bg bg




VaginitisChapter 48. Tuberculosis
bg bg bg bg




Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and
bg bg bg bg bg bg bg bg bg




OtitisExterna
bg g
b




Chapter 50. Urinary Tract
bg bg bg




InfectionChapter 51. Women as
bg bg bg bg bg

,Patients Chapter 52. Men as
bg bg bg bg bg




Patients Chapter 53. Pediatric
bg bg bg bg




Patients
bg




Chapter 54. Transgendered Clients as Patients
bg bg bg bg bg

,Chapter 55. Geriatric Patients
bg bg bg




Chapter 1. The Role of the Nurse
bg bg bg bg bg bg




PractitionerMultiple Choice
bg b
g bg




Identify the choice that best completes the statement or answers the question.
bg bg bg bg bg bg bg bg bg bg bg




bg bg bg b g 1. Nurse practitioner prescriptive authority is regulated by:
bg bg bg bg bg bg bg




1. The National Council of State Boards of Nursing bg bg bg bg bg bg bg




2. The U.S. Drug Enforcement Administration bg bg bg bg




3. The State Board of Nursing for each state bg bg bg bg bg bg bg




4. The State Board of Pharmacy bg bg bg bg




bg bg bg b g 2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN)
bg bg bg bg bg bg bg bg bg bg bg bg bg




prescriberinclude:
bg g
b




1. Nurses know more about Pharmacology than other prescribers because they take
bg bg bg bg bg bg bg bg bg bg




itboth in their basic nursing program and in their APRN program.
bg bg bg bg bg bg bg bg bg bg bg bg




2. Nurses care for the patient from a holistic approach and include the patient
bg bg bg bg bg bg bg bg bg bg bg bg




indecision making regarding their care.
bg bg bg bg bg bg




3. APRNs are less likely to prescribe narcotics and other controlled substances. bg bg bg bg bg bg bg bg bg bg




4. APRNs are able to prescribe independently in all states, whereas a bg bg bg bg bg bg bg bg bg bg




physician’sassistant needs to have a physician supervising their practice.
bg g
b bg bg bg bg bg bg bg bg




bg bg bg b g 3. Clinical judgment in prescribing includes:
bg bg bg bg bg




1. Factoring in the cost to the patient of the medication prescribed bg bg bg bg bg bg bg bg bg bg




2. Always prescribing the newest medication available for the disease process bg bg bg bg bg bg bg bg bg




3. Handing out drug samples to poor patients bg bg bg bg bg bg




4. Prescribing all generic medications to cut costs bg bg bg bg bg bg




bg bg bg b g 4. Criteria for choosing an effective drug for a disorder include:
bg bg bg bg bg bg bg bg bg bg




1. Asking the patient what drug they think would work best for them bg bg bg bg bg bg bg bg bg bg bg




2. Consulting nationally recognized guidelines for disease management bg bg bg bg bg bg




3. Prescribing medications that are available as samples before writing a prescription bg bg bg bg bg bg bg bg bg bg




4. Following U.S. Drug Enforcement Administration guidelines for prescribing bg bg bg bg bg bg bg




bg bg bg b g 5. Nurse practitioner practice may thrive under health-care reform because of:
bg bg bg bg bg bg bg bg bg bg




1. The demonstrated ability of nurse practitioners to control costs and improve
bg bg bg bg bg bg bg bg bg bg




patientoutcomes bg g
b




2. The fact that nurse practitioners will be able to practice independently
bg bg bg bg bg bg bg bg bg bg




3. The fact that nurse practitioners will have full reimbursement under health-
bg bg bg bg bg bg bg bg bg bg




carereform g
b




4. The ability to shift accountability for Medicaid to the state level
bg bg bg bg bg bg bg bg bg bg

, Chapter 1. The Role of the Nurse
bg bg bg bg bg bg




PractitionerAnswer Section
bg b
g bg




MULTIPLE CHOICE bg




1. ANS: bg bg b g 3 PTS: b g 1
2. ANS: bg bg b g 2 PTS: b g 1
3. ANS: bg bg b g 1 PTS: b g 1
4. ANS: bg bg b g 2 PTS: b g 1
5. ANS: bg bg b g 1 PTS: b g 1

Chapter 2. Review of Basic Principles of
bg bg bg bg bg bg




bg PharmacologyMultiple Choice b
g bg




Identify the choice that best completes the statement or answers the question.
bg bg bg bg bg bg bg bg bg bg bg




bg bg bg b g 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical
bg bg bg bg bg bg bg bg bg bg bg bg




toprescribing because:
bg bg bg




1. Distribution of drugs to target tissue may be affected. bg bg bg bg bg bg bg bg




2. The solubility of the drug will not match the site of absorption.
bg bg bg bg bg bg bg bg bg bg bg




3. There will be less free drug available to generate an effect. bg bg bg bg bg bg bg bg bg bg




4. Drugs bound to albumin are readily excreted by the kidneys. bg bg bg bg bg bg bg bg bg




bg bg bg b g 2. Drugs that have a significant first-pass effect:
bg bg bg bg bg bg bg




1. Must be given by the enteral (oral) route only bg bg bg bg bg bg bg bg




2. Bypass the hepatic circulation bg bg bg




3. Are rapidly metabolized by the liver and may have little if any desired action
bg bg bg bg bg bg bg bg bg bg bg bg bg




4. Are converted by the liver to more active and fat-soluble forms
bg bg bg bg bg bg bg bg bg bg




bg bg bg b g 3. The route of excretion of a volatile drug will likely be the:
bg bg bg bg bg bg bg bg bg bg bg bg




1. Kidneys
2. Lungs
3. Bile and feces bg bg




4. Skin

bg bg bg b g 4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a
bg bg bg bg bg bg bg bg bg bg




storagereservoir of the drug. Storage reservoirs:
bg bg bg bg bg bg bg




1. Assure that the drug will reach its intended target tissue bg bg bg bg bg bg bg bg bg




2. Are the reason for giving loading doses bg bg bg bg bg bg




3. Increase the length of time a drug is available and active bg bg bg bg bg bg bg bg bg bg




4. Are most common in collagen tissues bg bg bg bg bg




bg bg bg b g 5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
bg bg bg bg bg bg bg bg bg bg bg bg bg bg bg




1. Propensity to go to the target receptor bg bg bg bg bg bg




2. Biological half-life bg




3. Pharmacodynamics
4. Safety and side effects bg bg bg